Group B Streptococcus bacteremia elicits β C protein-specific IgM and IgG in humans

Journal of Infectious Diseases

Volumn 195, Issue 3, 2007, Pages 353-356

  Pannaraj, Pia S ^a,d   Kelly, Joanna K ^a   Madoff, Lawrence C ^b   Ranch, Marcia A ^a   Lachenauer, Catherine S ^c   Edwards, Morven S ^a   Baker, Carol J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BETA C PROTEIN; GLYCOCONJUGATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; NEWBORN; NONHUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOCOCCUS AGALACTIAE;

EID: 33846425719     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510627     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease-United States, 1996-2004. MMWR Morb Mortal Wkly Rep 2005; 54:1205-8.
2. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003; 21:3468-72.
3. Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 2005; 23:3187-95.
4. Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 1996; 98:2308-14.
5. Paoletti LC, Madoff LC. Vaccines to prevent neonatal GBS infection. Semin Neonatol 2002; 7:315-23.
6. Dagan R, Eskola J, Leclerc C, Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 1998; 66:2093-8.
7. Johnson DR, Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol 1984; 19:506-10.
8. Lindahl G, Stalhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 2005; 18:102-27.
9. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serorype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000; 96:498-503.
10. Lachenauer CS, Baker CJ, Baron MJ, Kasper DL, Gravekamp C, Madoff LC. Quantitative determination of immunoglobulin G specific for group B streptococcal β C protein in human maternal serum. J Infect Dis 2002; 185:368-74.
11. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981; 68:544-9.
12. Lancefield RC, McCarty M, Everly W. Multiple mouse-protective antibodies directed against group B streptococci: special reference to antibodies effective against protein antigens. J Exp Med 1975; 142:165-79.
13. Bevanger L, Naess AI. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand B 1985;93:121-4.
14. Michel JL, Madoff LC, Kling DE, Kasper DL, Ausubel FM. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun 1991; 59:2023-8.
15. Madoff LC, Michel JL, Gong EW, Rodewald AK, Kasper DL. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun 1992; 60:4989-94.
16. Madoff LC, Paoletti LC, Tai JY, Kasper DL. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest 1994; 94:286-92.
17. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294:753-6.
18. Davies HD, Adair C, McGeer A, et al. Antibodies to capsular polysaccharides of group B streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 2001; 184:285-91.
19. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis 1998; 177:998-1002.